This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of goal-concordant care using shared decision-making strategies. A challenging real-world case scenario discussion within each Gather-ed group highlights critical decision points, key challenges, and opportunities to incorporate collective insights.
- Provider:Haymarket Medical Education
- Activity Link: https://haymarket.gathered.com/curriculum/177
- Start Date: 2024-06-29 05:00:00
- End Date: 2024-06-29 05:00:00
- Credit Details: IPCE Credits: 4.25 hours
AMA PRA Category 1 Credit™️: 4.25 hours
Nursing: 4.25 hours
Pharmacy: 4.25 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 904625.0 - Is Kind Support: False
- Activity Type: Other/Blended Learning
- CME Finder Type: Other
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest